- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01178619
Sonographic Differences in Brain Measurements Between Normal and Intrauterine Growth Restriction (IUGR) Fetuses
August 27, 2013 updated by: Meir Medical Center
Intrauterine growth restriction is being suspected in cases where the fetal estimated weight is less then the 10 th percentile for its gestational age.
Abdominal circumference is the most influenced measurement in this cases.
Head circumference on the other hand can be or not be influenced.
Previous studies have shown that transverse cerebellar diameter (TCD) is constant to gestational age and is not influenced by IUGR.Other showed lower TCD in IUGR fetuses.
We would like to study the differences in cerebellar, vermian and corpus callosum growth between normal to IUGR fetuses and between symmetrical and asymmetrical IUGR.
In this observational study we will include pregnant women between 28-37 gestational week with a singleton otherwise normal pregnancies.
We will measure the fetal TCD, vermian distances and the CC, abdominal circumference, head circumference and femur length.
we will compeer these measurements according to the following groups:normal fetuses, symmetrical and asymmetrical IUGR.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 8 months (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
pregnant women 28-37 GA, singleton, otherwise normal fetuses
Description
Inclusion Criteria:
- singleton,
- 28-37 GA,
- well dated pregnancy.
Exclusion Criteria:
- multifetal pregnancies,
- no first trimester dating,
- fetuses with known chromosomal or structural anomalies.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
AGA
|
symmetrical IUGR
|
asymmetrical IUGR
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (ANTICIPATED)
August 1, 2012
Study Completion (ACTUAL)
August 1, 2012
Study Registration Dates
First Submitted
August 8, 2010
First Submitted That Met QC Criteria
August 9, 2010
First Posted (ESTIMATE)
August 10, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
August 28, 2013
Last Update Submitted That Met QC Criteria
August 27, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MMC10095-2010CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intra-uterine Growth Restriction
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedPregnant Women With Foetuses Presenting With Intra-uterine Growth RestrictionFrance
-
Hospices Civils de LyonUnknown
-
Central Hospital, Nancy, FranceEnrolling by invitationPreterm Birth | Neurodevelopmental Disorders | Placental Insufficiency | Severe Intra-uterine Growth Restriction
-
Nantes University HospitalTerminated
-
University of Colorado, DenverThe Perelman Family FoundationRecruiting
-
amera mohamedUnknownThe Relationship Between Second Trimester Placental Growth Factor Level and Fetal Growth RestrictionIntra Uterine Growth RetardationEgypt
-
Central Hospital, Nancy, FranceUnknownGenetic Disease | IUGR | Prenatal Disorder
-
Nantes University HospitalTerminatedIntra Uterine Growth RetardationFrance
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedChildren Born With Serious Intra-uterine Growth Retardation